High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma
References
Additional references
Al‐Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?. Pediatric Blood Cancer 2007;49(2):190‐5.
Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, et al. Prognostic factors in non metastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. Journal Clinical Oncology 2000;18(1):4‐11.
Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, et al. Allogeneic and autologous stem‐cell transplantation in advanced Ewing tumours. An update after long‐term follow‐up from two centers of the European Intergroup study EICESS. Stem‐Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Annals of Oncology 2000;11(11):1451‐62.
Cangir A, Vietti TJ, Gehan EA, Burgert EO, Thomas P, Tefft M, et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990;1;66(5):887‐93.
Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, et al. European intergroup studies (MMT4‐89 and MMT4‐91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. Journal of Clinical Oncology 2004;22(23):4787‐94.
Claviez A, Sureda A, Schmitz N. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma. Bone Marrow Transplantation 2008;42:Suppl 2:S16‐24.
Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. Journal Clinical Oncology 2000;18(17):3108‐14.
Delattre O, Zucman J, Melot T. The Ewing family of tumors ‐ a subgroup of small‐round‐cell tumors defined by specific chimeric transcripts. New England Journal of Medicine 1994;331:294‐9.
Drabko K, Zawitkowska‐Klaczynska J, Wojcik B, Choma M, Zaucha‐Prazmo A, Kowalczyk J. Mega chemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma. Pediatric Transplantation 2005;9(5):618‐21.
Esiashvili N, Goodman M, Marcus RB. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. Journal of Pediatric Hematology and Oncology 2008;30(6):425‐30.
Fraser CJ, Weigel BJ, Perentesis JP, Dusenbery KE, DeFor TE, Baker KS, et al. Autologous stem cell transplantation for high‐risk Ewing's sarcoma and other pediatric solid tumors. Bone Marrow Transplantation 2006;37(2):175‐81.
Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N. Children's Oncology Group's 2013 blueprint for research: bone tumors COG Bone Tumor Committee. Pediatric Blood Cancer 2013;60(6):1009‐15.
Gurney JG, Swensen AR, Bulterys M. Malignant bone tumours. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al. editor(s). Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975‐1999. Bethesda, MD: National Cancer Institute SEER Program, National Institutes of Health, 1999:99‐110.
Haeusler J, Ranft A, Boelling T, Gosheger G, Braun‐Munzinger G, Vieth V, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma. Cancer 2010;116:443‐50.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jenkin RD, Al‐Fawaz I, Al‐Shabanah MO, Allam A, Ayas M, Memon M, et al. Metastatic Ewing sarcoma/PNET of bone at diagnosis: prognostic factors ‐ a report from Saudi Arabia. Medical and Pediatric Oncology 2001;37(4):383‐9.
Kauer M, Ban J, Kofler R, Walker B, Davis S, Meltzer P, et al. A molecular function map of Ewing's sarcoma. PLoS One 2009;4(4):e5415.
Kushner BH, Meyers PA. How effective is dose‐intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan‐Kettering experience and a literature review. Clinical Oncology 2001;19(3):870‐80.
Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro‐EWING 99 trial. Journal of Clinical Oncology 2010;10,28(20):3284‐91.
Lee JA, Kim DH, Cho J, Lim JS, Koh JS, Yoo JY, et al. Treatment outcome of Korean patients with localized Ewing sarcoma family oftumors: a single institution experience. Japanese Journal of Clinical Oncology 2011;41(6):776‐82.
Matthay KK. Intensification of therapy using hematopoietic stem‐cell support for high‐risk neuroblastoma. Pediatric Transplantation 1999;3(Suppl 1):72‐7.
Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS. High‐dose melphalan, etoposide, total‐body irradiation, and autologous stem‐cell reconstitution as consolidation therapy for high‐risk Ewing's sarcoma does not improve prognosis. Journal of Clinical Oncology 2001;19(11):2812‐20.
Kremer LCM, van Dalen EC, Moher D, Caron HN. Cochrane Childhood Cancer Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs))2010, issue 12.
Ordóñez JL, Osuna D, Herrero D, de Álava E, Madoz‐Gúrpide J. "Advances in Ewing's sarcoma research: where are we now and what lies ahead?". Cancer Research 2009;69(18):7140‐50.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34.
Potratz J, Dirksen U, Jürgens H, Craft A. Ewing sarcoma: clinical state‐of‐the‐art. Pediatric Hematology and Oncology 2012;29:1‐11.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rosenthal J, Bolotin E, Shakhnovits M, Pawlowska A, Falk P. High‐dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors. Bone Marrow Transplantation 2008;42(5):311‐8.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P. Treatment of high‐risk relapsed Wilms tumor with dose‐intensive chemotherapy, marrow‐ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Pediatric Blood Cancer 2008;51(1):23‐8.
Teicher BA, Bagley RG, Rouleau C, Kruger A, Ren Y, Kurtzberg L. Characteristics of human Ewing/PNET sarcoma models. Annals of Saudi Medicine 2011;31(2):174‐82.
Van den Berg H, Kroon HM, Slaar A, Hogendoorn P. Incidence of biopsy‐proven bone tumors in children. A report based on the Dutch Pathology Registration "PALGA". Journal of Pediatric Orthopaedics 2008;28(1):29‐35.
